Nitin Tandon, Vijay Luxami, Runjhun Tandon and Kamaldeep Paul* Pages 1 - 17 ( 17 )
The recent emergence of novel, pathogenic COVID-19 disease associated with SARS-CoV-2 virus in China and its rapid national and international spread pose a global health emergency. The development of a new drug is tedious and may take decades to develop and involves multiple steps like development of prototypes and phase I to III human trials which involve the study on small to large populations to examine the safety and side effects associated with drug under trials. Due to continue increasing the confirmed cases and deaths, there is an urgent need to develop a drug that is effective to kill SARS-CoV-2 virus with fewer side effects to human body. Therefore, this review focus on the latest advances in the development for the treatment of COVID-19 disease associated with SARS-CoV-2 with repositioning of already marketed drug with small molecules, as well as Chinese traditional medicines with established safety and efficacy which are being used for different therapeutic uses.
SARS-CoV-2, Chloroquine, Hydroxychloroquine, Chinese traditional medicine, Inhibitors, Stem cells.
School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara-144411, School of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala-147004, School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara-144411, School of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala-147004